Susceptibility of pneumococci to evernimicin: effect of CO2 and different methodologies.
Hamilton-Miller
J M
JM
Department of Medical Microbiology, Royal Free and University College Medical School, London NW3 2PF, UK. j.hamilton-miller@rfc.ucl.ac.uk
Shah
S
S
Loebenberg
D
D
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002245:Carbon Dioxide / Q000009:adverse effects / Q000378:metabolism*; D003470:Culture Media; D004352:Drug Resistance, Microbial; D006863:Hydrogen-Ion Concentration; D008826:Microbial Sensitivity Tests / Q000379:methods* / Q000592:standards; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000378:metabolism
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D003470:Culture Media; D002245:Carbon Dioxide; C001202:evernimicin